E-drug: Counterfeit drugs? contact WHO
---------------------------------------------
[Cross-posted from afro-nets with thanks BS]
Encounter counterfeit drugs? -- The WHO would like to hear from you
---------------------------------------------------
* Reporting detected counterfeit drugs
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/reporting_cd.shtml
[Long URL will need 'repair']
"Combating the problem of counterfeit drugs is a shared
responsibility in which all concerned parties: government agencies,
pharmaceutical industries, drug suppliers, healthcare providers,
professional
associations, consumers and nongovernmental organizations and
international organizations have to participate.
In order to design and implement appropriate national as well
international anti-counterfeiting measures, it is necessary to have
access
to reliable information on the nature and magnitude of the problem.
In turn this requires the availability of an effective information
exchange system between all the concerned parties.
In order to promote this, WHO in 1996 developed and distributed two
types of Counterfeit Drugs Reporting Forms: Form DRS/CFD/RF.1 and
Form DRS/CFD/RF.2 to all its Member States. These forms have now been
revised and are available as Form A (CFD/RF.1) and Form B (CFD/RF.2).
National Drug Regulatory Authorities, Anti-counterfeiting Liaison
Officers, and others who detect counterfeit drugs are therefore
encouraged to fill these forms and send them to the address indicated
below.
Both Form A (English -- French) and Form B (English -- French) need
to be filled out for each case of counterfeit drug that is detected.
A case is defined by the stated active ingredient, dosage form, the
trade name on the label and batch number. If any one of these is
different then the case will be considered to be different.
Form A provides general information about the reporting authority,
country where the drug has been detected, date and site of detection,
etc., whereas Form B provides information about the detected drug,
active ingredient, trade name, dosage form, batch number, etc.
WHO will consolidate the information received on quarterly basis and
post it on its counterfeit drugs notification website.
For enquiries please contact:
Mr Eshetu Wondemagegnehu
Quality Assurance and Safety of Medicines
Essential Drugs and Medicines Policy (EDM)
World Health Organization
CH-1211 Geneva 27, Switzerland
Tel: +41-22-791-3743
Fax: +41-22-791-4730
Links to reporting forms:
[Long URLs will need 'repair']
Form A - (English):
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/cf_engforma.pdf
Form A - (French):
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/cf_frenchforma.pdf
Form B - (English):
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/cf_engformb.pdf
Form B - (French):
http://www.who.int/medicines/organization/qsm/activities/qualityassurance/counterfeit/cf_frenchformb.pdf
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug